Ardelyx, Inc. (ARDX)
6.155
-0.10
(-1.52%)
USD |
NASDAQ |
May 27, 16:00
6.19
+0.04
(+0.57%)
After-Hours: 17:36
Ardelyx Free Cash Flow : -37.50M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.597B |
| Syndax Pharmaceuticals, Inc. | -278.35M |
| ACADIA Pharmaceuticals, Inc. | 113.59M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
| Savara, Inc. | -106.97M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -32.24M |
| Cash from Investing (Quarterly) | -9.995M |
| Cash from Financing (Quarterly) | 5.442M |
| Free Cash Flow Per Share (Quarterly) | -0.1314 |
| Free Cash Flow to Equity (Quarterly) | -32.62M |
| Free Cash Flow to Firm (Quarterly) | -25.39M |
| Free Cash Flow Yield | -2.51% |